1. P1463: PHASE I DOSE ESCALATION OF LAVA-051, A NOVEL BISPECIFIC GAMMA-DELTA T-CELL ENGAGER (GAMMABODY™), IN RELAPSED/REFRACTORY HEMATOLOGICAL MALIGNANCIES. (23rd June 2022) Authors: Broijl, A.; van de Donk, N.; Bosch, F.; Mateos, M. V.; Rodriguez-Otero, P.; Tucci, A.; Ghia, P.; Adang, A.; Parren, P.; Tuinhof, I.; Umarale, S.; Winograd, B.; van der Vliet, H.; Kater, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1345 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗